Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Other Operating Expenses (2016 - 2026)

InflaRx's Other Operating Expenses history spans 9 years, with the latest figure at -$126524.8 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 91.75% to -$126524.8 in Q1 2026 year-over-year; TTM through Mar 2026 was -$13.0 billion, a 19.84% increase, with the full-year FY2022 number at -$53456.5 billion, changed N/A from a year prior.
  • Other Operating Expenses hit -$126524.8 in Q1 2026 for InflaRx, up from -$1.4 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for IFRX hit a ceiling of $19685.6 billion in Q1 2023 and a floor of -$53456.5 billion in Q4 2022.
  • Historically, Other Operating Expenses has averaged -$5370.6 billion across 5 years, with a median of -$1.7 million in 2023.
  • Biggest five-year swings in Other Operating Expenses: crashed 150947343.61% in 2023 and later soared 99.95% in 2024.
  • Tracing IFRX's Other Operating Expenses over 5 years: stood at -$53456.5 billion in 2022, then skyrocketed by 100.0% to -$1.7 million in 2023, then decreased by 10.26% to -$1.9 million in 2024, then increased by 27.1% to -$1.4 million in 2025, then surged by 90.75% to -$126524.8 in 2026.
  • Business Quant data shows Other Operating Expenses for IFRX at -$126524.8 in Q1 2026, -$1.4 million in Q3 2025, and -$13.0 billion in Q2 2025.